Skip to main content

Myrobalan Therapeutics

Medford, United States

Myrobalan Therapeutics is a biotechnology company developing oral neurorestorative therapies for individuals with CNS diseases.

$850K raised
Mar 2025
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Myrobalan Therapeutics

How much funding has Myrobalan Therapeutics raised?
Myrobalan Therapeutics has raised $850K in total funding. The most recent round was Grant. The last funding was announced in March 2025.
Who are Myrobalan Therapeutics's investors?
Myrobalan Therapeutics's investors include 3E Bioventures, National Multiple Sclerosis Society (NMSS), Cowin Venture, The ALS Association, AB Magnitude Ventures Group.
Where is Myrobalan Therapeutics headquartered?
Myrobalan Therapeutics is headquartered in Medford, United States.
What does Myrobalan Therapeutics do?
Myrobalan Therapeutics is a biotechnology company developing oral neurorestorative therapies for individuals with CNS diseases.
What stage is Myrobalan Therapeutics at?
Myrobalan Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Myrobalan Therapeutics — Funding & Investors." VCBacked, March 13, 2025, https://www.vcbacked.co/company/myrobalan-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Myrobalan Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/myrobalan-therapeutics
Wikipedia (cite web)
{{cite web |title=Myrobalan Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/myrobalan-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .